Lomustine FDA approval date

The FDA approved Lomustine (CCNU) on 4 Aug 1976.

FDA approval date
4 Aug 1976

Drug identity checked against registry records

Also recorded as CCNU; CeeNU; Gleostine; Lomustine Capsules

Included trials

TrialSponsorPhaseStatusPrimary completion
9-ING-41 in Patients With Advanced CancersNCT03678883ACTUPhase 2Active not recruiting2026-06Estimated
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeNCT04762069CNSPPhase 2Active not recruiting2026-04-27Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
1976-08-04DayLomustineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA017588", "applicant_as_listed_by_fda": "AZURITY", "brand_names": ["GLEOSTINE"], "active_ingredients": ["LOMUSTINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19760804", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026